Stay updated on Cirmtuzumab Consolidation after Venetoclax in CLL Clinical Trial

Sign up to get notified when there's something new on the Cirmtuzumab Consolidation after Venetoclax in CLL Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Cirmtuzumab Consolidation after Venetoclax in CLL Clinical Trial page

  1. Check
    yesterday
    Change Detected
    Summary
    The page has updated its date information, adding several future dates while removing some past dates. Notably, the new dates include events scheduled for May 2025 and July 2026.
    Difference
    1%
    Check dated 2025-05-07T19:34:00.000Z thumbnail image
  2. Check
    8 days ago
    Change Detected
    Summary
    The web page has been updated from version 2.15.0 to version 2.15.2, indicating a revision in the content.
    Difference
    0.1%
    Check dated 2025-04-30T14:20:23.000Z thumbnail image
  3. Check
    15 days ago
    No Change Detected
  4. Check
    22 days ago
    Change Detected
    Summary
    The page has undergone significant changes, including the removal of detailed descriptions of a phase 2 study on cirmtuzumab and venetoclax, while adding references to Chronic Lymphocytic Leukemia and collaborators involved in the study.
    Difference
    26%
    Check dated 2025-04-16T10:36:33.000Z thumbnail image
  5. Check
    30 days ago
    Change Detected
    Summary
    The web page has been updated from version 2.14.3 to version 2.14.4.
    Difference
    0.1%
    Check dated 2025-04-09T05:15:17.000Z thumbnail image
  6. Check
    44 days ago
    Change Detected
    Difference
    0.7%
    Check dated 2025-03-25T13:21:21.000Z thumbnail image
  7. Check
    52 days ago
    Change Detected
    Difference
    0.7%
    Check dated 2025-03-18T06:17:47.000Z thumbnail image

Stay in the know with updates to Cirmtuzumab Consolidation after Venetoclax in CLL Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Cirmtuzumab Consolidation after Venetoclax in CLL Clinical Trial page.